Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial)
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 March 2025
|
| In: |
Clinical cancer research
Year: 2025, Jahrgang: 31, Heft: 5, Pages: 860-867 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-24-2461 |
| Online-Zugang: | Resolving-System, lizenzpflichtig: https://doi.org/10.1158/1078-0432.CCR-24-2461
|
| Verfasserangaben: | Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, and Mathias M. Weber |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1914731433 | ||
| 003 | DE-627 | ||
| 005 | 20250716222600.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250115s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1078-0432.CCR-24-2461 |2 doi | |
| 035 | |a (DE-627)1914731433 | ||
| 035 | |a (DE-599)KXP1914731433 | ||
| 035 | |a (OCoLC)1528016525 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fottner, Christian |d 1971- |e VerfasserIn |0 (DE-588)1271385015 |0 (DE-627)1820194175 |0 (DE-576)134349237 |4 aut | |
| 245 | 1 | 0 | |a Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial) |c Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, and Mathias M. Weber |
| 264 | 1 | |c 1 March 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 540 | |q DE-3 |a Urheberrechtsschutz 1.0 |2 rs |u http://rightsstatements.org/vocab/InC/1.0/ | ||
| 700 | 1 | |a Apostolidis, Leonidas |d 1981- |e VerfasserIn |0 (DE-588)139136932 |0 (DE-627)703220594 |0 (DE-576)309798590 |4 aut | |
| 700 | 1 | |a Krug, Sebastian |d 1985- |e VerfasserIn |0 (DE-588)1014103975 |0 (DE-627)705168034 |0 (DE-576)348318332 |4 aut | |
| 700 | 1 | |a Rinke, Anja |e VerfasserIn |0 (DE-588)108413151X |0 (DE-627)848313631 |0 (DE-576)456188924 |4 aut | |
| 700 | 1 | |a Grün, Barbara |e VerfasserIn |0 (DE-588)1161226311 |0 (DE-627)1024632121 |0 (DE-576)506420922 |4 aut | |
| 700 | 1 | |a Michl, Patrick |d 1971- |e VerfasserIn |0 (DE-588)121336328 |0 (DE-627)081239203 |0 (DE-576)292654677 |4 aut | |
| 700 | 1 | |a Gress, Thomas Mathias |d 1962- |e VerfasserIn |0 (DE-588)1036248712 |0 (DE-627)749801549 |0 (DE-576)383750172 |4 aut | |
| 700 | 1 | |a Wagner, Daniel-Christoph |d 1979- |e VerfasserIn |0 (DE-588)1016231865 |0 (DE-627)671239007 |0 (DE-576)351695516 |4 aut | |
| 700 | 1 | |a Roth, Wilfried |d 1970- |e VerfasserIn |0 (DE-588)120891557 |0 (DE-627)080951279 |0 (DE-576)292433484 |4 aut | |
| 700 | 1 | |a Mettler, Esther Maria |d 1979- |e VerfasserIn |0 (DE-588)1175402966 |0 (DE-627)1046335170 |0 (DE-576)516170759 |4 aut | |
| 700 | 1 | |a Topsch, Jana |d 1976- |e VerfasserIn |0 (DE-588)12989947X |0 (DE-627)483347760 |0 (DE-576)297893165 |4 aut | |
| 700 | 1 | |a Ruckes, Christian Rainer |d 1971- |e VerfasserIn |0 (DE-588)1213115671 |0 (DE-627)1703437349 |4 aut | |
| 700 | 1 | |a Galle, Peter R. |d 1957- |e VerfasserIn |0 (DE-588)1111061963 |0 (DE-627)865474168 |0 (DE-576)475908953 |4 aut | |
| 700 | 1 | |a Weber, Mathias M. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cancer research |d Philadelphia, Pa. [u.a.] : AACR, 1995 |g 31(2025), 5, Seite 860-867 |h Online-Ressource |w (DE-627)325489971 |w (DE-600)2036787-9 |w (DE-576)094502234 |x 1557-3265 |7 nnas |a Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial) |
| 773 | 1 | 8 | |g volume:31 |g year:2025 |g number:5 |g pages:860-867 |g extent:8 |a Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial) |
| 856 | 4 | 0 | |u https://doi.org/10.1158/1078-0432.CCR-24-2461 |x Resolving-System |z lizenzpflichtig |
| 951 | |a AR | ||
| 992 | |a 20250312 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 121336328 |a Michl, Patrick |m 121336328:Michl, Patrick |d 910000 |d 910100 |e 910000PM121336328 |e 910100PM121336328 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1014103975 |a Krug, Sebastian |m 1014103975:Krug, Sebastian |d 910000 |d 910100 |e 910000PK1014103975 |e 910100PK1014103975 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 139136932 |a Apostolidis, Leonidas |m 139136932:Apostolidis, Leonidas |d 910000 |d 910100 |d 50000 |e 910000PA139136932 |e 910100PA139136932 |e 50000PA139136932 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1914731433 |e 4686352428 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, and Mathias M. Weber"]},"recId":"1914731433","person":[{"family":"Fottner","role":"aut","display":"Fottner, Christian","given":"Christian"},{"family":"Apostolidis","role":"aut","display":"Apostolidis, Leonidas","given":"Leonidas"},{"role":"aut","family":"Krug","given":"Sebastian","display":"Krug, Sebastian"},{"display":"Rinke, Anja","given":"Anja","family":"Rinke","role":"aut"},{"family":"Grün","role":"aut","display":"Grün, Barbara","given":"Barbara"},{"role":"aut","family":"Michl","display":"Michl, Patrick","given":"Patrick"},{"given":"Thomas Mathias","display":"Gress, Thomas Mathias","family":"Gress","role":"aut"},{"given":"Daniel-Christoph","display":"Wagner, Daniel-Christoph","family":"Wagner","role":"aut"},{"family":"Roth","role":"aut","given":"Wilfried","display":"Roth, Wilfried"},{"display":"Mettler, Esther Maria","given":"Esther Maria","family":"Mettler","role":"aut"},{"given":"Jana","display":"Topsch, Jana","role":"aut","family":"Topsch"},{"family":"Ruckes","role":"aut","given":"Christian Rainer","display":"Ruckes, Christian Rainer"},{"family":"Galle","role":"aut","display":"Galle, Peter R.","given":"Peter R."},{"given":"Mathias M.","display":"Weber, Mathias M.","family":"Weber","role":"aut"}],"title":[{"title_sort":"Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial)","title":"Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial)"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1914731433"],"doi":["10.1158/1078-0432.CCR-24-2461"]},"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"relHost":[{"origin":[{"publisherPlace":"Philadelphia, Pa. [u.a.]","dateIssuedKey":"1995","dateIssuedDisp":"1995-","publisher":"AACR"}],"title":[{"title":"Clinical cancer research","title_sort":"Clinical cancer research"}],"id":{"issn":["1557-3265"],"eki":["325489971"],"zdb":["2036787-9"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"325489971","name":{"displayForm":["American Association for Cancer Research"]},"disp":"Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial)Clinical cancer research","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"role":"isb","display":"American Association for Cancer Research"}],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1995 -"],"language":["eng"],"part":{"text":"31(2025), 5, Seite 860-867","extent":"8","pages":"860-867","issue":"5","year":"2025","volume":"31"}}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"1 March 2025"}]} | ||
| SRT | |a FOTTNERCHRACTIVITYAN1202 | ||